The Journal of Drugs in Dermatology (JDD) continues to be a leading dermatology journal, presenting original articles, award-winning case studies, clinical trial reviews and clearance updates, drugs and devices, and special content geared toward medical residents and other allied health professionals.
JDD is a top-tier, highly cited, peer-reviewed publication that has been indexed with MEDLINE®/PubMed® since Issue 1-1. JDD utilizes an unbiased, balanced peer-review process in order to maintain high standards of content. Articles are reviewed by the Editorial Board of renowned experts, from key opinion leaders to well-known clinicians.
To learn more about Institutional, Library, & Corporate subscriptions, please contact our sales team here or use the form below.